Monalizumab (KLRC1/NKG2A/CD159a/CD94) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer:
PRS-10-731
| Artikelname: |
Monalizumab (KLRC1/NKG2A/CD159a/CD94) - Research Grade Biosimilar, Unconjugated, Monoclonal |
| Artikelnummer: |
PRS-10-731 |
| Hersteller Artikelnummer: |
10-731 |
| Alternativnummer: |
PRS-10-731-0.1 |
| Hersteller: |
ProSci |
| Kategorie: |
Antikörper |
| Immunogen: |
Humanized / KLRC1/NKG2A/CD159a/CD94 [Homo sapiens] |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
IPH-2201,NN-8765,NNC-0141-0000-0100,NNC-141-01000,anti-NKG2A,humZ270 |
| Klonalität: |
Monoclonal |
| Konzentration: |
batch dependent |
| Puffer: |
PBS buffer pH7.5 |
| Quelle: |
CHO cells |
| Application Verdünnung: |
Optimal dilutions for each application to be determined by the researcher. |
